Voriconazole Inhibits Fungal Growth without Impairing Antigen Presentation or T-Cell Activation

AUTOR(ES)

Van Epps, Heather L.

FONTE

American Society for Microbiology

RESUMO

Invasive aspergillosis (IA) is the most common life-threatening invasive mold infection worldwide. The principal therapy for IA is amphotericin B, despite its known toxicity and immunosuppressive side effects. Studies in animal models of IA suggest a role for T lymphocytes in the pathology of the disease, although the precise role for Aspergillus-specific T cells remains undefined. The isolation and characterization of T lymphocytes in animal models of IA are hampered by the rapid outgrowth of the fungus in cultures derived from infected organs. In the present study, we tested the abilities of the antifungal drugs caspofungin acetate and voriconazole to inhibit fungal growth in vitro as a means of maintaining cultures of T cells from Aspergillus-infected mice. We demonstrate that while both antifungal drugs are inhibitory, only voriconazole completely inhibited fungal growth, allowing long-term maintenance of T-cell cultures. In addition, voriconazole had no inhibitory effect on the activation and maturation of dendritic cells or the proliferation of T lymphocytes. Thus, voriconazole appears to be a promising agent for use in in vitro studies of Aspergillus-specific T lymphocytes in animal models of IA.

Documentos Relacionados

• T-cell activation by peptide antigen: effect of peptide sequence and method of antigen presentation.
• T-cell activation without proliferation in juvenile idiopathic arthritis
• Antigen conformation determines processing requirements for T-cell activation
• Antigen conformation determines processing requirements for T-cell activation.
• T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones.